The concentrations of Amyloid-beta(1-42) (Aβ42), total Tau (Tau), and Tau phosphorylated at position 181 (pTau) in cerebrospinal fluid (CSF) of AD patients can be used as biomarkers [3]. Here, MAPT is linked to Alzheimer disease.